Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,406.50
Bid: 1,405.00
Ask: 1,405.50
Change: -7.50 (-0.53%)
Spread: 0.50 (0.036%)
Open: 1,417.50
High: 1,418.50
Low: 1,386.50
Prev. Close: 1,414.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Appointment

13 Dec 2013 14:23

RNS Number : 5294V
Persimmon PLC
13 December 2013
 

 

Persimmon Plc (the "Company")

 

Directorate Change and Director Shareholding

 

Persimmon Plc is pleased to announce the appointment of David Jenkinson (B.A. Hons), North Division Chief Executive as an Executive Director with effect from 13 December 2013.

 

David Jenkinson (46) has been the Divisional Chief Executive of Persimmon's North Division since January 2013 with responsibility for twelve regions from the East Midlands to Scotland. He has worked in the housebuilding industry since 1995 and has a degree in Town & Country Planning. Mr Jenkinson has been with Persimmon for over 16 years and previous roles include Managing Director of Persimmon Homes North East and Regional Managing Director.

 

Nicholas Wrigley, Chairman, commented "Dave will bring a wealth of operational experience to the Board. His appointment again demonstrates the strength of our divisional management teams and the Company's ability to promote internal candidates to the Board in accordance with our succession planning policy."

 

There are no further details required to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Jenkinson's appointment.

 

Following Mr Jenkinson's appointment to the Board an option has been granted to him today under the Persimmon Plc 2012 Long Term Incentive Plan (the Plan) over 460,523 shares at an option price of £11.355. This award is subject to the performance condition set out in the rules of the Plan, in summary being the return of £6.20 per share to shareholders by the end of 2021. The awards may vest up to 40% in December 2017 and the remainder in 2021.

 

As a result Mr Jenkinson holds options/awards over 1,698,567 ordinary shares granted under the Company's various share schemes.

 

The issued share capital of the Company on 13 December 2013 is 304,627,407 shares.

 

 

G N Francis

Group Company Secretary

 

 

 

 

Notes to Editors:

 

About Persimmon

Persimmon plc was established in 1972 and has become one of Britain's leading housebuilders. The Group's Head Office is in York and Persimmon has 24 regional offices nationwide. The Group operates under three main brands; Persimmon Homes, Charles Church and Westbury Partnerships.

 

The Persimmon Homes business builds quality houses which provide the very best in design, construction and service. Charles Church provides a range of premium houses, in both modern and traditional styles. Westbury Partnerships focuses on social housing using modern methods of construction supplied by Space4, our timber frame manufacturing business.

 

For more information about Persimmon please go to www.corporate.persimmonhomes.com 

 

Further information, please contact:

 

Persimmon plc Citigate Dewe Rogerson

Jeff Fairburn, Group Chief Executive Simon Rigby

Mike Killoran, Group Finance Director Kevin Smith

 

Tel: +44 (0)1904 642199 Tel: +44 (0)20 7638 9571

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFFFLDFDSEEE
Date   Source Headline
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.